Digital Storytelling Intervention for Cancer Patients Undergoing Hematopoietic Cell Transplantation

Overview

About this study

The study is testing the effectiveness of digital story intervention in caregivers of patients who have recently undergone transplant for hematopoietic cell malignancies. Research has shown that viewing presentation of HCT stories from individuals who have similar experiences with their diagnosis and treatment and have a wide range of emotional expression or resolutions have beneficial effects on emotional wellbeing. We will use the information from this study to help us to evaluate the use of this intervention to minimize emotional distress among HCT caregivers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Phase 1
    • Adult HCT survivors (18 years or older) who have completed transplant within the past 2 years, any gender, race or ethnicity. Able to speak, read, and write English.
  • Phase 2
    • Adult patients (18 years or older) undergoing HCT for a hematological malignancy, any gender, race or ethnicity. Able to speak, read, and write English.

Exclusion Criteria

  • Cognitive impairment that would prevent them from fully participating.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Nandita Khera, M.D., M.P.H.

Open for enrollment

Contact information:

Regina Becker

(480)342-6079

Becker.Regina@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20309315

Mayo Clinic Footer